CADL
Candel Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.78
−1.46%Leverage
- Debt / equity
- 0.39x
- Net debt / equity
- -1.21x
- Debt / assets
- 0.24x
- Debt / EBITDA
- -0.60x
- Net debt / EBITDA
- 1.83x
Liquidity & coverage
- Current ratio
- 16.09x
- Quick ratio
- 16.09x
- Cash ratio
- 15.89x
- Interest coverage
- -15.26x
- EBITDA / interest
- -17.60x
- Working capital
- $191.5M
Cash & dividend
- FCF / debt
- -1.16x
- Cash flow / debt
- -1.13x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026